Past and present treatment of pancreatic adenocarcinoma: Chemotherapy as a standard treatment modality

被引：25

作者：

Abbruzzese, JL ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期

关键词：

D O I：

10.1053/sonc.2002.37382

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2 / 8

页数：7

共 47 条

[1]

Abbruzzese James L., 1994, Cancer Bulletin (Houston), V46, P525

[2] A PHASE-I CLINICAL, PLASMA, AND CELLULAR PHARMACOLOGY STUDY OF GEMCITABINE [J].

ABBRUZZESE, JL ;

GRUNEWALD, R ;

WEEKS, EA ;

GRAVEL, D ;

ADAMS, T ;

NOWAK, B ;

MINEISHI, S ;

TARASSOFF, P ;

SATTERLEE, W ;

RABER, MN ;

PLUNKETT, W .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (03) :491-498

[3]

ABBRUZZESE JL, 2001, P AN M AM SOC CLIN, V20, pA130

[4]

Adjei AA, 2000, CANCER RES, V60, P1871

[5] IFOSFAMIDE AND MESNA - MARGINALLY ACTIVE IN PATIENTS WITH ADVANCED-CARCINOMA OF THE PANCREAS [J].

AJANI, JA ;

ABBRUZZESE, JL ;

GOUDEAU, P ;

FAINTUCH, JS ;

YEOMANS, AC ;

BOMAN, BM ;

NICAISE, C ;

LEVIN, B .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (11) :1703-1707

[6]

[Anonymous], 2001, CANC PRICIPLES PRACT

[7]

BISSERY MC, 1991, CANCER RES, V51, P4845

[8] Marimastat as first-line therapy for patients with unresectable pancreatic cancer: A randomized trial [J].

Bramhall, SR ;

Rosemurgy, A ;

Brown, PD ;

Bowry, C ;

Buckels, JAC .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (15) :3447-3455

[9]

Bruns CJ, 2000, CANCER RES, V60, P2926

[10]

Bruns CJ, 2000, CLIN CANCER RES, V6, P1936

← 1 2 3 4 5 →